Richard W. Hevner served in the U.S. Marines and is an executive with Wells Fargo Advisors, LLC. While he may not seem an obvious choice to spearhead a bold breast cancer initiative, that’s exactly what he’s doing as part of his role on the Sidney Kimmel Cancer Center Advisory Council.
Known as Project 200K by 2024, the initiative aims to increase mammograms within the Jefferson Enterprise to 200,000 per year in just six years. It’s a goal that Hevner is passionate about achieving: “By increasing the number of mammograms, we can also perform more biopsies and surgical procedures and, ultimately, save more lives. To do it, we need to improve access and ensure quality and consistency throughout the enterprise.”
The Project 200K by 2024 benchmark is the latest institutional challenge issued and navigated by Hevner. While Chair of the Board of Trustees, he led the merger of Thomas Jefferson University and Thomas Jefferson University Hospital, as well as the mergers with Abington, Aria, Philadelphia University and Kennedy. He also spearheaded Jefferson’s novel model of shared governance. His ongoing leadership was recently recognized with the investiture of Isidore Rigoutsos, PhD, as the first Richard W. Hevner Professor of Computational Medicine in the Jefferson College of Life Sciences.
"A Bold Benchmark,"
Jefferson Surgical Solutions: Vol. 13:
2, Article 3.
Available at: https://jdc.jefferson.edu/jss/vol13/iss2/3